John Ricci, MD
Family Medicine · Red Bank, NJNPI 1043383987
Payments from drug & device makers
Across 243 payments — averaging $30.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Novo Nordisk$1K
- Pfizer$484
- Biohaven Pharmaceutical Holding Company Ltd.$442
- GSK$425
- Amarin Pharma, Inc.$357
- plus $2K from 27 others
What the payments were for
- Speaking & faculty fees$1,07515%
- Travel & lodging$1392%
- Food & beverage$6,16083%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 72 | $2,218 |
| Novo Nordisk | 39 | $1,100 |
| Pfizer | 17 | $484 |
| Biohaven Pharmaceutical Holding Company Ltd. | 18 | $442 |
| GSK | 7 | $425 |
| Amarin Pharma, Inc. | 4 | $357 |
| Lundbeck LLC | 10 | $340 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $332 |
| Eisai Inc. | 7 | $204 |
| AstraZeneca(2 entities) | 7 | $203 |
| Galderma Laboratories, L.p. | 1 | $150 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $141 |
| Amgen | 1 | $125 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $125 |
| Optinose US, Inc. | 1 | $109 |
| Genentech USA, Inc. | 1 | $96 |
| Tolmar, Inc. | 6 | $95 |
| Lilly USA, LLC | 5 | $80 |
| Teva Pharmaceuticals USA, Inc. | 4 | $57 |
| Merck | 3 | $44 |
| Daiichi Sankyo Inc. | 2 | $32 |
| Nalpropion Pharmaceuticals LLC | 2 | $29 |
| Sanofi-aventis U.S. LLC | 2 | $26 |
| Boston Scientific | 1 | $23 |
| Exact Sciences | 1 | $22 |
| Clarus Therapeutics Inc. | 2 | $21 |
| Antares Pharma, Inc. | 1 | $15 |
| Endo Pharmaceuticals Inc. | 1 | $15 |
| Orthogenrx Inc. | 1 | $14 |
| Boehringer Ingelheim | 1 | $14 |
| Aytu Biopharma, Inc. | 1 | $14 |
| Halozyme Inc | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,379 in reported general payments places this provider in the 90th percentile of 2,084 family medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in Red Bank
- Howard HassmanClementon$47.1M
- Matthew HongNorth Cape May$15.3M
- Rubaba HussainClark$3.8M
- Gaurang BrahmbhattHoboken$2.6M
- Michael DobrowClifton$2.1M
- Mikhail VarshavskiChatham$1.4M
- Amit BhalodiaCamden$707K
- Jennifer AmicoNew Brunswick$627K
- Janet ColeFar Hills$466K
- Matthew PintoMarlton$239K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.